Skip to content

Exploring how to commercialise medical technology

At a recent Medical Technology Workshop, experts shared their perspectives on the challenges of bringing ideas to commercial and clinical fruition - exploring all aspects of medical technology development and commercialisation.

Experts from government, industry, health and education sectors spoke about the development, clinical validation and funding models needed to bring medical technologies to the clinic in order to improve health across the community.

Deputy Principal of the UNSW Medicine Cancer Theme and workshop convenor, A/Prof Phoebe Phillips explained,

“The best chance for commercialisation of your medical technology is starting with a clinical problem, strategically select the best interdisciplinary team, have an intellectual property plan, ensure there is a market for your technology and integrate a regulatory approval strategy throughout pipeline,” she said.

“I was motivated by the willingness of the MedTech industry and entrepreneurs to share their expertise and advice freely with academics.  I look forward to building these relationships to support academics and increase partnerships with industry to foster translation.”

Read the workshop program or watch the four workshop sessions for more tips:

·      SESSION 1: Project Development to Proof of Concept

·      SESSION 2: Product Development, Clinical Validation, and Market Entry

·      SESSION 3: Partnerships and Funding

·      SESSION 4: Case Studies

The workshop was sponsored by UNSW Medicine and two clinical academic groups (CAGs) from the Maridulu Budyari Gumal (SPHERE) network, the Triple I CAG and Cancer CAG. It was facilitated by Professor Joanne Tipper (co-director of Frontiers Technology CAG) from UTS.

Early/mid-career cancer researchers awarded Cancer Clinical Academic Group seed grants

Maridulu Budyari Gumal (SPHERE) Cancer Clinical Academic Group has committed $100,000 in new seed grants for two interdisciplinary projects led by early/mid-career researchers (EMCRs) to be undertaken in 2021.

Congratulations to the successful awardees and their teams.

New liquid biopsies could provide hope for brain cancer patients

Increasing the efficacy of brain cancer treatment traditionally requires access to tissue samples that can shed light on a tumour’s genetic makeup. But, with many malignancies buried deep inside essential areas of the brain, this tissue is often impossible to reach.

A new research project led by Associate Professor Therese Becker of the Ingham Institute is aiming to solve this problem. Using ‘liquid biopsies’ – that is, blood tests – the researchers hope to reveal critical information about individual patient tumours. 

Implementation Science Webinar

Maridulu Budyari Gumal SPHERE Implementation Science Platform hosted an Implementation Science Webinar on 18th November 2020.